- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/096 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Patent holdings for IPC class C07D 295/096
Total number of patents in this class: 348
10-year publication summary
44
|
38
|
40
|
26
|
20
|
28
|
17
|
21
|
10
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
H. Lundbeck A/S | 1244 |
28 |
Lek Pharmaceuticals d.d. | 210 |
9 |
vTv Therapeutics LLC | 154 |
9 |
Novartis AG | 11254 |
8 |
The Johns Hopkins University | 5540 |
7 |
Cardioxyl Pharmaceuticals, Inc. | 49 |
7 |
Reneo Pharmaceuticals, Inc. | 23 |
7 |
Johnson Matthey Public Limited Company | 1861 |
5 |
Emory University | 1592 |
4 |
Metabolys | 7 |
4 |
Sunshine Lake Pharma Co., Ltd. | 572 |
4 |
Bristol-myers Squibb Company | 4861 |
3 |
Sandoz AG | 1404 |
3 |
National Institute of Advanced Industrial Science and Technology | 3736 |
3 |
University of Florida Research Foundation, Inc. | 3965 |
3 |
Ben-Gurion University of the Negev Research and Development Authority | 213 |
3 |
Biogen MA Inc. | 917 |
3 |
Cadila Healthcare Limited | 323 |
3 |
Sutter Bay Hospitals | 15 |
3 |
Teijin Pharma Limited | 251 |
3 |
Other owners | 229 |